vs
SHOULDER INNOVATIONS, INC.（SI）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
TriSalus Life Sciences, Inc.的季度营收约是SHOULDER INNOVATIONS, INC.的1.1倍（$13.2M vs $11.8M），TriSalus Life Sciences, Inc.净利率更高（-73.9% vs -74.3%，领先0.4%），TriSalus Life Sciences, Inc.自由现金流更多（$-2.5M vs $-11.4M）
Shoulder Innovations Inc是一家专注于肩关节置换手术相关骨科医疗器械研发、生产与商业化的医疗科技企业，旗下产品可降低手术并发症风险、优化患者预后，主要面向北美、西欧等市场的骨科医师及医疗机构发售。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
SI vs TLSI — 直观对比
营收规模更大
TLSI
是对方的1.1倍
$11.8M
净利率更高
TLSI
高出0.4%
-74.3%
自由现金流更多
TLSI
多$8.8M
$-11.4M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.8M | $13.2M |
| 净利润 | $-8.7M | $-9.8M |
| 毛利率 | 76.2% | 86.7% |
| 营业利润率 | -65.0% | -24.8% |
| 净利率 | -74.3% | -73.9% |
| 营收同比 | — | 59.8% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $-0.64 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SITLSI
| Q4 25 | — | $13.2M | ||
| Q3 25 | $11.8M | $11.6M | ||
| Q2 25 | $11.0M | $11.2M | ||
| Q1 25 | — | $9.2M | ||
| Q4 24 | — | $8.3M | ||
| Q3 24 | — | $7.3M | ||
| Q2 24 | — | $7.4M | ||
| Q1 24 | — | $6.5M |
净利润SITLSI
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $-8.7M | $-10.8M | ||
| Q2 25 | $-19.2M | $-8.3M | ||
| Q1 25 | — | $-10.4M | ||
| Q4 24 | — | $-10.1M | ||
| Q3 24 | — | $-2.4M | ||
| Q2 24 | — | $-4.3M | ||
| Q1 24 | — | $-13.2M |
毛利率SITLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | 76.2% | 83.5% | ||
| Q2 25 | 76.2% | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率SITLSI
| Q4 25 | — | -24.8% | ||
| Q3 25 | -65.0% | -77.9% | ||
| Q2 25 | -53.2% | -65.4% | ||
| Q1 25 | — | -79.9% | ||
| Q4 24 | — | -91.8% | ||
| Q3 24 | — | -118.9% | ||
| Q2 24 | — | -111.0% | ||
| Q1 24 | — | -180.8% |
净利率SITLSI
| Q4 25 | — | -73.9% | ||
| Q3 25 | -74.3% | -93.5% | ||
| Q2 25 | -174.3% | -73.9% | ||
| Q1 25 | — | -113.2% | ||
| Q4 24 | — | -122.4% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | — | -58.8% | ||
| Q1 24 | — | -204.5% |
每股收益（稀释后）SITLSI
| Q4 25 | — | $-0.22 | ||
| Q3 25 | $-0.64 | $-0.96 | ||
| Q2 25 | $-165.53 | $-0.27 | ||
| Q1 25 | — | $-0.39 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | — | $-0.12 | ||
| Q2 24 | — | $-0.21 | ||
| Q1 24 | — | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $54.9M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $147.8M | $-33.9M |
| 总资产 | $177.8M | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SITLSI
| Q4 25 | — | $20.4M | ||
| Q3 25 | $54.9M | $22.7M | ||
| Q2 25 | $27.1M | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $4.0M |
股东权益SITLSI
| Q4 25 | — | $-33.9M | ||
| Q3 25 | $147.8M | $-26.7M | ||
| Q2 25 | $-78.2M | $-19.4M | ||
| Q1 25 | — | $-34.4M | ||
| Q4 24 | — | $-25.9M | ||
| Q3 24 | — | $-20.4M | ||
| Q2 24 | — | $-25.3M | ||
| Q1 24 | — | $-36.0M |
总资产SITLSI
| Q4 25 | — | $35.3M | ||
| Q3 25 | $177.8M | $36.5M | ||
| Q2 25 | $77.8M | $41.3M | ||
| Q1 25 | — | $28.6M | ||
| Q4 24 | — | $24.0M | ||
| Q3 24 | — | $27.5M | ||
| Q2 24 | — | $32.4M | ||
| Q1 24 | — | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.6M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $-11.4M | $-2.5M |
| 自由现金流率自由现金流/营收 | -96.7% | -19.1% |
| 资本支出强度资本支出/营收 | 23.9% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-19.1M |
8季度趋势，按日历期对齐
经营现金流SITLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-8.6M | $-3.7M | ||
| Q2 25 | $-11.3M | $-7.3M | ||
| Q1 25 | — | $-4.5M | ||
| Q4 24 | — | $-5.7M | ||
| Q3 24 | — | $-10.8M | ||
| Q2 24 | — | $-13.4M | ||
| Q1 24 | — | $-10.9M |
自由现金流SITLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-11.4M | $-3.9M | ||
| Q2 25 | $-13.6M | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
自由现金流率SITLSI
| Q4 25 | — | -19.1% | ||
| Q3 25 | -96.7% | -33.9% | ||
| Q2 25 | -123.4% | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
资本支出强度SITLSI
| Q4 25 | — | 0.3% | ||
| Q3 25 | 23.9% | 1.9% | ||
| Q2 25 | 21.0% | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
